BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7405109)

  • 1. [Organization and results of cytological study of women in prophylactic gynecologic examinations].
    Mel nik AN; Buval tseva NA
    Vopr Onkol; 1980; 26(7):69-70. PubMed ID: 7405109
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of cytological screening during prophylactic examinations of women in detecting precancer and cancer of the cervix uteri--the screening results of 1971-1981 in the People's Republic of Bulgaria].
    Tsanev K; Aleksieva A; Manolova Ia; Damianov P; Toshev I
    Akush Ginekol (Sofiia); 1983; 22(3):210-2. PubMed ID: 6660408
    [No Abstract]   [Full Text] [Related]  

  • 3. [Organization and efficacy of cytological examinations in the mass screening of women in the Moldavian SSR].
    Khonelidze GB; Lazarev IM; Cheban DA; Zavtur LV
    Vopr Onkol; 1984; 30(9):91-4. PubMed ID: 6238482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Standardization of the cytological results attained in conducting prophylactic gynecological examinations].
    Novik VI; Puchkov IuG
    Vopr Onkol; 1985; 31(3):92-6. PubMed ID: 3992965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
    Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic examinations for uterine cervix cancer in the female inhabitants of Bialystok District.
    Soszka S
    Pol Med J; 1970; 9(4):1019-26. PubMed ID: 5477483
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early diagnosis of concer of the uterine cervix during prophylactic examinations under rural conditions].
    Fridman IA
    Vopr Onkol; 1969; 15(9):89-93. PubMed ID: 4242915
    [No Abstract]   [Full Text] [Related]  

  • 8. [HPV test for quality control of gynecologic cytological tests].
    Wilander E; Wikström I
    Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3560, 3564. PubMed ID: 19133586
    [No Abstract]   [Full Text] [Related]  

  • 9. [Organization of prophylactic gynecologic exams with mass cytological screening of women].
    Buval'tseva NA; Kvashenko BK
    Pediatr Akus Ginekol; 1978; (3):35-6. PubMed ID: 673514
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy of cytodiagnosis of cervix cancer during prophylactic examinations].
    Gladysheva VA; Chernova VD; Ivanova AV
    Lab Delo; 1982; (9):519-21. PubMed ID: 6183511
    [No Abstract]   [Full Text] [Related]  

  • 11. Problems of cytological screening in a young urban population.
    Savage EW; Chapman GW
    Urban Health; 1977 Mar; 6(2):31, 33-4. PubMed ID: 10235788
    [No Abstract]   [Full Text] [Related]  

  • 12. [Campaign for cervical cancer screening with vaginal smears in women aged 50-69 years in Isère (France). Results of the first round (January 1991-June 1993)].
    Garnier A; Exbrayat C; Bolla M; Marron J; Winckel P; Billette de Villemeur A
    Bull Cancer; 1997 Aug; 84(8):791-5. PubMed ID: 9339183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The case against cytological mass screening for cervical cancer in Israel].
    Menczer J
    Harefuah; 1992 Jun; 122(12):802-4. PubMed ID: 1505832
    [No Abstract]   [Full Text] [Related]  

  • 14. [Data processing in the planning, organization and evaluation of cytologic cancer prevention examinations].
    Schneider ML; Soost HJ; Stolley H
    Methods Inf Med Suppl; 1976; 8():371-6. PubMed ID: 1078511
    [No Abstract]   [Full Text] [Related]  

  • 15. [Follow-up of non-negative cervical cytological smears in the county of Funen].
    Dahl MB; Hølund B; Sørensen B; Ahrons S; Grinsted P; Poulsen EF
    Ugeskr Laeger; 1998 Sep; 160(40):5798-801. PubMed ID: 9782760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of gynecologic cancer screening, including cytological studies, in Budapest (1976-1978)].
    Miklós B; János S; Lajos D; Iván L; Nándor F
    Orv Hetil; 1981 Mar; 122(9):509-11. PubMed ID: 7290695
    [No Abstract]   [Full Text] [Related]  

  • 17. Cervical screening. Rate of diagnosis of cytological abnormalities is best end point.
    Williamson S; Wadehra V
    BMJ; 1997 Apr; 314(7089):1277. PubMed ID: 9154040
    [No Abstract]   [Full Text] [Related]  

  • 18. The International Academy of Cytology's policy statement on the frequency of gynecologic screening.
    Anal Quant Cytol; 1980 Sep; 2(3):153-4. PubMed ID: 7425436
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mass screening for cervical cancer. A one-year registration of cervical cytological tests].
    Bjørge T; Gunbjørud AB; Langmark F; Skare GB; Thoresen SO
    Tidsskr Nor Laegeforen; 1994 Jan; 114(3):341-5. PubMed ID: 8191435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.